Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism c-Kit inhibitors(Stem cell growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic macular oedema | Phase 2 | South Korea | - | |
Dystrophy, Macular | Phase 2 | South Korea | - | |
Neoplasms | Phase 2 | South Korea | - | |
Diabetic macular oedema | Preclinical | South Korea | - | |
Dystrophy, Macular | Preclinical | South Korea | - | |
Neoplasms | Preclinical | South Korea | - |